Cargando…

Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs

Detalles Bibliográficos
Autores principales:	Berger, Edward A., Pastan, Ira
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883583/ https://www.ncbi.nlm.nih.gov/pubmed/20548940 http://dx.doi.org/10.1371/journal.ppat.1000803

Ejemplares similares

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020)

Immunotoxins: From Design to Clinical Application
por: Kreitman, Robert J., et al.
Publicado: (2021)

Immunogenicity of Immunotoxins Containing Pseudomonas Exotoxin A: Causes, Consequences, and Mitigation
por: Mazor, Ronit, et al.
Publicado: (2020)

Mechanisms of Resistance to Immunotoxins Containing Pseudomonas Exotoxin A in Cancer Therapy
por: Dieffenbach, Michael, et al.
Publicado: (2020)

Immunotoxins: A Review of Their Use in Cancer Treatment
por: Aruna, G
Publicado: (2006)

Targeting malignant B cells with an immunotoxin against ROR1
por: Baskar, Sivasubramanian, et al.
Publicado: (2012)

Efficiency of Immunotoxin Cytotoxicity Is Modulated by the Intracellular Itinerary
por: Tortorella, Lori L., et al.
Publicado: (2012)

Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient’s Bedside to Evaluation in Preclinical Models
por: Leshem, Yasmin, et al.
Publicado: (2019)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies
por: Müller, Fabian, et al.
Publicado: (2017)

Effect of Antigen Shedding on Targeted Delivery of Immunotoxins in Solid Tumors from a Mathematical Model
por: Pak, Youngshang, et al.
Publicado: (2014)

Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results
por: Mason-Osann, Emily, et al.
Publicado: (2015)

EGFR/EGFRvIII-targeted immunotoxin therapy for the treatment of glioblastomas via convection-enhanced delivery
por: Bao, Xuhui, et al.
Publicado: (2016)

Combination Treatments with the PKC Inhibitor, Enzastaurin, Enhance the Cytotoxicity of the Anti-Mesothelin Immunotoxin, SS1P
por: Mattoo, Abid R., et al.
Publicado: (2013)

Panbinostat decreases cFLIP and enhances killing of cancer cells by immunotoxin LMB-100 by stimulating the extrinsic apoptotic pathway
por: Liu, Xiu-Fen, et al.
Publicado: (2017)

Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structures
por: Liu, Wenlong, et al.
Publicado: (2022)

Limits on Replenishment of the Resting CD4(+) T Cell Reservoir for HIV in Patients on HAART
por: Sedaghat, Ahmad R, et al.
Publicado: (2007)

Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line
por: Hollevoet, Kevin, et al.
Publicado: (2015)

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
por: Wang, Chunguang, et al.
Publicado: (2016)

Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity
por: Mazor, Ronit, et al.
Publicado: (2016)

Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A
por: Kaplan, Gilad, et al.
Publicado: (2016)

Combining anti-CTLA4 with RG7787, an immunotoxin targeting mesothelin, promotes tumor eradication
por: Leshem, Jasmin, et al.
Publicado: (2015)

SS1P Immunotoxin Induces Markers of Immunogenic Cell Death and Enhances the Effect of the CTLA-4 Blockade in AE17M Mouse Mesothelioma Tumors
por: Leshem, Yasmin, et al.
Publicado: (2018)

CD3-immunotoxin mediated depletion of T cells in lymphoid tissues of rhesus macaques
por: Wang, Lan, et al.
Publicado: (2023)

Low-level HIV-1 replication and the dynamics of the resting CD4(+ )T cell reservoir for HIV-1 in the setting of HAART
por: Sedaghat, Ahmad R, et al.
Publicado: (2008)

Subcortical brain atrophy persists even in HAART-regulated HIV disease
por: Becker, James T., et al.
Publicado: (2011)

Depletion of HIV reservoir by activation of ISR signaling in resting CD4(+) T cells
por: Li, Dajiang, et al.
Publicado: (2022)

An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells
por: Cai, Yingyun, et al.
Publicado: (2021)

Hidden reservoir of resistant parasites: the missing link in the elimination of falciparum malaria
por: Abdul-Ghani, Rashad, et al.
Publicado: (2017)

HIV-1 infection in dendritic cells in HAART suppressed patients
por: Maldonado, lrvin M, et al.
Publicado: (2006)

Depletion of Specific Cell Populations by Complement Depletion
por: Dittel, Bonnie N.
Publicado: (2010)

HIV-1 variants are archived throughout infection and persist in the reservoir
por: Brooks, Kelsie, et al.
Publicado: (2020)

Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART
por: Denton, Paul W., et al.
Publicado: (2014)

Recent Common Ancestry of Ebola Zaire Virus Found in a Bat Reservoir
por: Biek, Roman, et al.
Publicado: (2006)

Persistence of Pathological Distribution of NK Cells in HIV-Infected Patients with Prolonged Use of HAART and a Sustained Immune Response
por: Frias, Mario, et al.
Publicado: (2015)

IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation
por: Fernandes, Jason R., et al.
Publicado: (2017)

Complement Factors in COVID-19 Therapeutics and Vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer—a preclinical study
por: Wang, Guannan, et al.
Publicado: (2022)

Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients
por: Bera, T K, et al.
Publicado: (2018)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4n8cd2kat6b3plh8d5hc4tj6mo